ICU MED INC's ticker is ICUI and the CUSIP is 44930G107. A total of 280 filers reported holding ICU MED INC in Q4 2020. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $21,259 | -33.0% | 178,639 | +0.3% | 0.21% | -28.9% |
| Q2 2023 | $31,732 | +6.9% | 178,080 | -1.0% | 0.30% | +4.9% |
| Q1 2023 | $29,678 | +6.2% | 179,908 | +1.4% | 0.29% | +1.4% |
| Q4 2022 | $27,941 | -99.9% | 177,424 | -1.8% | 0.28% | -5.7% |
| Q3 2022 | $27,203,000 | -11.3% | 180,632 | -3.2% | 0.30% | -9.4% |
| Q2 2022 | $30,669,000 | -22.7% | 186,563 | +4.6% | 0.33% | -6.5% |
| Q1 2022 | $39,698,000 | +36.4% | 178,306 | +45.4% | 0.35% | +45.7% |
| Q4 2021 | $29,104,000 | +0.8% | 122,627 | -0.9% | 0.24% | -5.8% |
| Q3 2021 | $28,886,000 | +12.8% | 123,773 | -0.5% | 0.26% | +15.7% |
| Q2 2021 | $25,603,000 | -0.0% | 124,404 | -0.2% | 0.22% | -5.5% |
| Q1 2021 | $25,605,000 | -3.7% | 124,633 | +0.5% | 0.24% | -15.4% |
| Q4 2020 | $26,597,000 | -24.4% | 124,002 | -35.6% | 0.28% | -39.5% |
| Q3 2020 | $35,201,000 | -25.9% | 192,606 | -25.3% | 0.46% | -31.0% |
| Q2 2020 | $47,535,000 | -33.0% | 257,908 | -26.6% | 0.67% | -46.5% |
| Q1 2020 | $70,930,000 | +12.8% | 351,543 | +4.6% | 1.25% | +48.6% |
| Q4 2019 | $62,895,000 | +13.4% | 336,119 | -3.3% | 0.84% | +7.7% |
| Q3 2019 | $55,457,000 | -44.4% | 347,480 | -12.3% | 0.78% | -48.5% |
| Q2 2019 | $99,776,000 | +3.3% | 396,076 | -1.8% | 1.51% | -2.7% |
| Q1 2019 | $96,559,000 | +2.0% | 403,454 | -2.2% | 1.56% | -16.7% |
| Q4 2018 | $94,688,000 | -20.4% | 412,350 | -2.0% | 1.87% | -2.4% |
| Q3 2018 | $118,977,000 | -3.7% | 420,784 | -0.0% | 1.91% | -5.5% |
| Q2 2018 | $123,595,000 | +6.3% | 420,892 | -8.6% | 2.02% | +3.1% |
| Q1 2018 | $116,251,000 | +19.0% | 460,583 | +1.8% | 1.96% | +17.6% |
| Q4 2017 | $97,688,000 | +6.1% | 452,259 | -8.7% | 1.67% | +8.8% |
| Q3 2017 | $92,044,000 | +7.6% | 495,259 | -0.1% | 1.53% | +3.9% |
| Q2 2017 | $85,508,000 | +16.0% | 495,697 | +2.7% | 1.48% | +6.3% |
| Q1 2017 | $73,737,000 | +1.9% | 482,889 | -1.6% | 1.39% | -1.3% |
| Q4 2016 | $72,334,000 | +3.0% | 490,896 | -11.6% | 1.41% | +6.7% |
| Q3 2016 | $70,210,000 | +14.9% | 555,549 | +2.5% | 1.32% | +4.5% |
| Q2 2016 | $61,131,000 | +8.9% | 542,184 | +0.5% | 1.26% | +1.4% |
| Q1 2016 | $56,150,000 | -4.4% | 539,386 | +3.5% | 1.24% | -9.9% |
| Q4 2015 | $58,764,000 | +0.9% | 521,048 | -2.0% | 1.38% | -0.7% |
| Q3 2015 | $58,224,000 | +7.1% | 531,724 | -6.4% | 1.39% | +12.5% |
| Q2 2015 | $54,344,000 | +0.8% | 568,092 | -1.9% | 1.24% | +0.8% |
| Q1 2015 | $53,923,000 | +13.6% | 578,942 | -0.1% | 1.23% | +8.1% |
| Q4 2014 | $47,454,000 | +30.3% | 579,420 | +2.1% | 1.13% | +18.6% |
| Q3 2014 | $36,420,000 | +6.7% | 567,460 | +1.1% | 0.96% | +10.6% |
| Q2 2014 | $34,133,000 | +7.1% | 561,306 | +5.5% | 0.86% | +1.2% |
| Q1 2014 | $31,866,000 | -6.9% | 532,158 | -0.9% | 0.85% | -8.4% |
| Q4 2013 | $34,221,000 | -4.8% | 537,143 | +1.5% | 0.93% | -15.1% |
| Q3 2013 | $35,956,000 | +7.8% | 529,309 | +14.4% | 1.10% | -11.0% |
| Q2 2013 | $33,340,000 | – | 462,671 | – | 1.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EVR Research LP | 22,000 | $4,719,000 | 3.86% |
| NUANCE INVESTMENTS, LLC | 901,483 | $193,359,000 | 3.73% |
| Nitorum Capital, L.P. | 417,241 | $89,494,000 | 3.46% |
| Tamarack Advisers, LP | 73,000 | $15,452,000 | 3.22% |
| PFM Health Sciences, LP | 267,817 | $57,444,000 | 2.02% |
| KIRR MARBACH & CO LLC /IN/ | 22,222 | $4,766,000 | 1.49% |
| PURA VIDA INVESTMENTS, LLC | 174,399 | $37,407,000 | 1.36% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 2,584 | $554,000 | 0.88% |
| Findlay Park Partners LLP | 528,825 | $113,428,000 | 0.79% |
| Altium Capital Management LP | 9,321 | $1,999,000 | 0.75% |